| Mr Gregory Tood Brooks, MD | |
|
2820 16th St Ne, Hickory, NC 28601-9600 | |
| (828) 304-0840 | |
| (828) 304-0943 |
| Full Name | Mr Gregory Tood Brooks |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 2820 16th St Ne, Hickory, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285724260 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9900780 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gentiva Health Services | Hickory, NC | Home health agency |
| Catawba Regional Hospice | Newton, NC | Hospice |
| Catawba Valley Medical Center | Hickory, NC | Hospital |
| Frye Regional Medical Center | Hickory, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catawba Valley Medical Group Inc | 6305007279 | 83 |
News Archive
Results from Project ImPACT: Osteoporosis were discussed today during the Annual Meeting of the American Pharmacists Association. Published in the March/April 2004 issue of the Journal of the American Pharmacists Association the authors, Jean-Venable "Kelly" Goode, Kim Swiger, and Benjamin M. Bluml, suggest that when patients, pharmacists and physicians collaborate closely, using pharmacy-based testing to identify and refer patients who are at-risk for future fracture that breakthrough results are possible.
Older adults with low levels of vitamin D appear more likely to experience declines in thinking, learning and memory over a six-year period, according to a report in the July 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).
In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found.
A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori - a known cause of gastritis, ulcer disease and cancer.
› Verified 2 days ago
| Entity Name | Catawba Valley Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790062362 PECOS PAC ID: 6305007279 Enrollment ID: O20120420000030 |
News Archive
Results from Project ImPACT: Osteoporosis were discussed today during the Annual Meeting of the American Pharmacists Association. Published in the March/April 2004 issue of the Journal of the American Pharmacists Association the authors, Jean-Venable "Kelly" Goode, Kim Swiger, and Benjamin M. Bluml, suggest that when patients, pharmacists and physicians collaborate closely, using pharmacy-based testing to identify and refer patients who are at-risk for future fracture that breakthrough results are possible.
Older adults with low levels of vitamin D appear more likely to experience declines in thinking, learning and memory over a six-year period, according to a report in the July 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).
In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found.
A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori - a known cause of gastritis, ulcer disease and cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gregory Tood Brooks, MD 2820 16th St Ne, Hickory, NC 28601-9600 Ph: (828) 304-0840 | Mr Gregory Tood Brooks, MD 2820 16th St Ne, Hickory, NC 28601-9600 Ph: (828) 304-0840 |
News Archive
Results from Project ImPACT: Osteoporosis were discussed today during the Annual Meeting of the American Pharmacists Association. Published in the March/April 2004 issue of the Journal of the American Pharmacists Association the authors, Jean-Venable "Kelly" Goode, Kim Swiger, and Benjamin M. Bluml, suggest that when patients, pharmacists and physicians collaborate closely, using pharmacy-based testing to identify and refer patients who are at-risk for future fracture that breakthrough results are possible.
Older adults with low levels of vitamin D appear more likely to experience declines in thinking, learning and memory over a six-year period, according to a report in the July 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A phase 3 trial of brentuximab vedotin (BV), the first new drug for Hodgkin lymphoma in over 30 years, shows that adults with hard-to-treat Hodgkin lymphoma given BV immediately after stem cell transplant survived without the disease progressing for twice as long as those given placebo (43 months vs 24 months).
In multiple sclerosis, a defective response of the body's own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found.
A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori - a known cause of gastritis, ulcer disease and cancer.
› Verified 2 days ago
Reginald G Moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 49th Avenue Pl Nw, Hickory, NC 28601 Phone: 828-381-3636 Fax: 828-728-2030 | |
Dr. Mary J. Britton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Tate Blvd Se Ste 186, Hickory, NC 28602 Phone: 828-449-8458 Fax: 828-323-8348 | |
Dr. Paige Kimbrell Parker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 N Center St, Hickory, NC 28601 Phone: 828-324-1699 | |
Wayne Vincent Wilson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1232 Shiloh Church Rd, Hickory, NC 28601 Phone: 828-495-4445 Fax: 828-495-4449 | |
Michael Burton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 2nd Ave Ne, Hickory, NC 28601 Phone: 828-328-2231 Fax: 828-323-1562 | |
Dr. Jason Kihneman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 29th Ave Ne, Hickory, NC 28601 Phone: 828-326-0658 |